| pubmed-article:11884046 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11884046 | lifeskim:mentions | umls-concept:C0555952 | lld:lifeskim |
| pubmed-article:11884046 | lifeskim:mentions | umls-concept:C0253023 | lld:lifeskim |
| pubmed-article:11884046 | lifeskim:mentions | umls-concept:C1519249 | lld:lifeskim |
| pubmed-article:11884046 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11884046 | pubmed:dateCreated | 2002-3-8 | lld:pubmed |
| pubmed-article:11884046 | pubmed:abstractText | Fas ligand (FasL) expression by cancer cells may mediate tumour immune privilege. The purpose of the present study was to investigate the timing and significance of FasL expression during the colorectal adenoma-carcinoma sequence. | lld:pubmed |
| pubmed-article:11884046 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11884046 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11884046 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11884046 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11884046 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11884046 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11884046 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11884046 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11884046 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11884046 | pubmed:issn | 0748-7983 | lld:pubmed |
| pubmed-article:11884046 | pubmed:author | pubmed-author:EspositoGG | lld:pubmed |
| pubmed-article:11884046 | pubmed:author | pubmed-author:LiseMM | lld:pubmed |
| pubmed-article:11884046 | pubmed:author | pubmed-author:NittsRR | lld:pubmed |
| pubmed-article:11884046 | pubmed:author | pubmed-author:BellucoCC | lld:pubmed |
| pubmed-article:11884046 | pubmed:author | pubmed-author:GiacomelliLL | lld:pubmed |
| pubmed-article:11884046 | pubmed:author | pubmed-author:BianchiL CLC | lld:pubmed |
| pubmed-article:11884046 | pubmed:author | pubmed-author:BertorelleRR | lld:pubmed |
| pubmed-article:11884046 | pubmed:author | pubmed-author:AlaggioRR | lld:pubmed |
| pubmed-article:11884046 | pubmed:copyrightInfo | Copyright Harcourt Publishers Limited. | lld:pubmed |
| pubmed-article:11884046 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11884046 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:11884046 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11884046 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11884046 | pubmed:pagination | 120-5 | lld:pubmed |
| pubmed-article:11884046 | pubmed:dateRevised | 2009-7-23 | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:meshHeading | pubmed-meshheading:11884046... | lld:pubmed |
| pubmed-article:11884046 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11884046 | pubmed:articleTitle | Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence. | lld:pubmed |
| pubmed-article:11884046 | pubmed:affiliation | Division of Surgery, Department of Oncological and Surgical Sciences, Padova, Italy. claudio.belluco@unipd.it | lld:pubmed |
| pubmed-article:11884046 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11884046 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884046 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884046 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884046 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884046 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11884046 | lld:pubmed |
